Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinopharm Group Luya (Shandong) Pharmaceutical is a Chinese pharmaceutical company specializing in the manufacture and sale of chemical drugs, antibiotics, and immunotherapeutic biologics. Originally established as Shandong Luya Pharmaceutical, the company was acquired by Winteam Pharmaceutical (now China Traditional Chinese Medicine Holdings, a subsidiary of Sinopharm). Its flagship product is Sapylin (OK-432), a lyophilized preparation of Streptococcus pyogenes used as an immunotherapeutic agent for various cancers, lymphatic malformations, and postoperative lymphatic leakage. Additionally, the company produces Cefodizime Sodium (Gaode), a third-generation cephalosporin antibiotic used to treat bacterial infections.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Luya Pharmaceutical.